CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Open-market buy Interim CEO bought 60,900 shares at an average $0.82 ($50,056)
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Director nominations
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy CEO bought 10,000 shares at an average $0.87 ($8,725)
- 4 Open-market buy Chief Financial Officer bought 17,500 shares at $0.85 ($14,910)
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 4 Other acquisition CEO acquired 176 shares (other)
- 4 Other acquisition Director acquired 282 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 169 shares (other)
- 4 Other acquisition Director acquired 71 shares (other)
- 4 Other acquisition Director acquired 528 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 211 shares (other)
- 4 Other acquisition Director acquired 74 shares (other)
- SC 13G Stake Amended Statement of Ownership
- 10-K Report Annual Report
Page 31 of 47 · 929 filings